LEAP Strategy for Neovascular Age-Related Macular Degeneration

计划入组 240 人 · 首次发布于 2026 年 8 月 4 日

VEGF Gene Association With Response to Neovascular Age-related Macular Degeneration With Anti-VEGF Agents

计划入组 74 人 · 首次发布于 2012 年 8 月 2 日

Intravitreal Injections by Nurses and Physicians Compared

计划入组 328 人 · 首次发布于 2015 年 2 月 9 日

anti-fibrosis agents

AAV-Anti-VEGF

Anti-VEGF biologics

Novel Anti-Infective Technologies, LLC

AiCuris Anti-Infective Cures AG

Germany

AGENCE REGIONALE DE SANTE DE LA REUNION

Reunion

Optigo Biotherapeutics Advances Long-Acting Anti-VEGF Therapy XPK-640 Toward IND-Enabling Studies

Real-World Evidence Guides Extended Dosing Strategies for Next-Generation Anti-VEGF Therapies in Retinal Disease

Real-World Study Affirms Long-Term Benefits of Anti-VEGF Therapy for Neovascular AMD